Nathalie Laarakker
Director/Board Member at OXURION NV
Profile
Nathalie Laarakker is currently the Chief Financial Officer & Director at Intravacc BV since 2021.
She is also an Independent Non-Executive Director at Oxurion NV since 2023.
Previously, she held the position of Chief Financial Officer & Managing Director at Gadeta BV and Head-Finance at Merus NV.
Ms. Laarakker completed her undergraduate degree at the University of Amsterdam.
Nathalie Laarakker active positions
| Companies | Position | Start |
|---|---|---|
| OXURION NV | Director/Board Member | 2023-05-01 |
| Intravacc BV | Director/Board Member | 2020-12-31 |
Former positions of Nathalie Laarakker
| Companies | Position | End |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | - |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Corporate Officer/Principal | - |
Training of Nathalie Laarakker
| University of Amsterdam | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OXURION NV | Health Technology |
| MERUS N.V. | Health Technology |
| Private companies | 2 |
|---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
| Intravacc BV |
- Stock Market
- Insiders
- Nathalie Laarakker
